全文获取类型
收费全文 | 355篇 |
免费 | 17篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 3篇 |
妇产科学 | 21篇 |
基础医学 | 59篇 |
口腔科学 | 6篇 |
临床医学 | 19篇 |
内科学 | 64篇 |
皮肤病学 | 1篇 |
神经病学 | 25篇 |
特种医学 | 64篇 |
外科学 | 18篇 |
综合类 | 2篇 |
预防医学 | 14篇 |
眼科学 | 4篇 |
药学 | 29篇 |
肿瘤学 | 42篇 |
出版年
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 4篇 |
2018年 | 7篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 9篇 |
2014年 | 5篇 |
2013年 | 14篇 |
2012年 | 19篇 |
2011年 | 20篇 |
2010年 | 14篇 |
2009年 | 10篇 |
2008年 | 18篇 |
2007年 | 23篇 |
2006年 | 19篇 |
2005年 | 25篇 |
2004年 | 16篇 |
2003年 | 13篇 |
2002年 | 17篇 |
2001年 | 11篇 |
2000年 | 13篇 |
1999年 | 10篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1990年 | 5篇 |
1989年 | 15篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1983年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1974年 | 4篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1970年 | 4篇 |
1969年 | 1篇 |
1967年 | 3篇 |
1966年 | 1篇 |
1961年 | 2篇 |
1960年 | 1篇 |
1958年 | 1篇 |
1939年 | 1篇 |
1938年 | 1篇 |
1937年 | 1篇 |
1936年 | 1篇 |
排序方式: 共有374条查询结果,搜索用时 0 毫秒
1.
2.
Kolárová H Huf M Macedek J Nevrelová P Tomecka M Bajgar R Mosinger J Strnad M 《Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové》2004,47(4):313-315
Photodynamic therapy of cancer uses the interaction of sensitizers and light to destroy cancer cells. In this study we tested the cellular uptake of meso-tetrakis(4-sulfonatophenyl)porphine (TPPS4) and its complex PdTPPS4 in the presence or absence of 2-hydroxypropyl-cyclodextrins (hpCDs) on G361 human melanoma cells. Self-fluorescence in G361 cells were measured by Perkin-Elmer LS50B luminometer equipped with well plate reader accessory. Morphological changes in cells have been evaluated using inversion fluorescent microscope Olympus IX 70 and image analysis. The uptake of the sensitizer PdTPPS4 at the given time interval from 1 to 48 hours is markedly higher than the uptake of TPPS4. The highest uptake was found for sensitizer PdTPPS4 in combination with hpbetaCD. TPPS4 and PdTPPS4 especially in the supramolecular complex with nontoxic cyclodextrin carriers represent efficient sensitizers for photodynamic therapy in vitro on G361 cells. 相似文献
3.
F. Strnad E. Buchborn du Mesnil H. Jahrmärker Schiebler Hartmann H. Ehrhart F. May 《Journal of molecular medicine (Berlin, Germany)》1960,38(5):238-242
Ohne Zusammenfassung 相似文献
4.
Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine 下载免费PDF全文
Markus A. Rose Ralf Schubert Nicola Strnad Stefan Zielen 《Clinical and Vaccine Immunology : CVI》2005,12(10):1216-1222
Pneumococcal polysaccharide vaccine (PPV) is of limited immunogenicity in infants and immunocompromised patients. Our prospective randomized controlled trial investigated whether priming with pneumococcal conjugate vaccine (PCV) induced specific immunological memory in previously nonresponders to PPV. Of a total of 33 children (2 to 18 years) with polysaccharide-specific immunodeficiency (PSI), group A (n = 16) received two doses of 7-valent PCV in a 4- to 6-week interval, and a booster dose of 23-valent PPV after one year. Group B (n = 17) received two doses of PPV in a 1-year interval exclusively. Specific antibody concentrations for serotypes 4, 5, 6B, 9V, 14, 18C, 19F, and 23F were determined (enzyme-linked immunosorbent assay) before and at 7 and 28 days after administration of the PPV booster and compared to an opsonophagocytosis assay. Of group A, 64 to 100% had antibody concentrations of ≥1 μg/ml on day 28 after the booster versus 25 to 94% of group B. Group A had significantly higher antibody concentrations for all PCV-containing serotypes already on day 7, indicating early memory response. Antibody concentrations were in accordance with functional opsonic activity, although opsonic titers varied among individuals. Pneumococcal vaccination was well tolerated. The incidence of airway infections was reduced after priming with PCV (10/year for group A versus 15/year for group B). Following a PPV booster, even patients primarily not responding to PPV showed a rapid and more pronounced memory response after priming with PCV. 相似文献
5.
H. Scheller H. E. Bock M. Knedel R. Marx Linneweh Struppler Schettler F. Strnad 《Journal of molecular medicine (Berlin, Germany)》1958,36(7):334-336
Ohne Zusammenfassung 相似文献
6.
Adjuvant treatment of patients with endometrial cancer depends on clinical and pathological risk factors. For low risk endometrial cancer the standard treatment is surgery alone without any adjuvant therapy. For intermediate risk endometrial cancer the use of postoperative radiation therapy should be limited to the group of patients with a sufficiently high risk of locoregional recurrence (15% or more) to warrant the risk of treatment-associated morbidity and in order to maximize initial local control and relapse-free survival. Recent data suggest that vaginal brachytherapy alone should preferably be used to reduce the risk of vaginal relapse with less morbidity and better quality of life. For high risk disease the combination of platin-based chemotherapy and radiation therapy is the most effective adjuvant treatment. Unanswered questions currently remaining are the selection of drugs for combination with platin, how many cycles and the sequence of chemotherapy in relation to radiation therapy. For the answers to these questions the results of ongoing randomized trials must be awaited. 相似文献
7.
Vermeulen K Strnad M Havlícek L Van Onckelen H Lenjou M Nijs G Van Bockstaele DR Berneman ZN 《Experimental hematology》2002,30(10):1107-1114
OBJECTIVE: Regulation of the cell cycle by cyclin-dependent kinase (CDK) activity occurs at multiple levels and is often altered in human cancers. Therefore, CDK activity has been targeted for drug discovery, and a number of small molecules have now been identified as CDK inhibitors. Plant cytokinin analogues with CDK inhibitory activity and antiproliferative effects were studied to characterize the cellular basis of the cytotoxic effect. METHODS: The IC(50) value (concentration at which 50% of the cell proliferation is inhibited) and AC(50) value (concentration at which 50% of the cell population is apoptotic) were determined by flow cytometry and microscopy, respectively. A new multiparametric flow cytometric analysis was used to study the sequence of different apoptotic events. In this assay, analysis of phosphatidylserine exposure, mitochondrial membrane depolarization, activation of caspases and DNA condensation were combined. RESULTS: Treatment of Jurkat and KG1 cells with the CDK inhibitors results in a decrease of viable cells and a parallel increase in percentage of apoptotic cells. Apoptosis was accompanied by a rapid decrease of mitochondrial membrane potential, which precedes DNA condensation, exposure of phosphatidylserine and activation of caspases. CONCLUSIONS: The main cellular mechanism of the antiproliferative effect of plant cytokinin analogues with CDK inhibitory activity is the induction of apoptosis. The multiparametric flow cytometric technique allowed to follow the kinetics of various aspects of apoptotic cell changes and demonstrated that cytokinin analogue-induced apoptosis starts through the mitochondrial pathway. This technique could also become of value for the rapid screening of pro-apoptotic properties of chemotherapeutic compounds. 相似文献
8.
9.
Katrin Mueller Yoshiaki Sunami Michael Stuetzle Nurdan Guldiken Ozlem Kucukoglu Sebastian Mueller Hasan Kulaksiz Peggy Schwarz Pavel Strnad 《The Journal of pathology》2013,231(4):532-542
The liver is the central regulator of iron metabolism and accordingly, chronic liver diseases often lead to systemic iron overload due to diminished expression of the iron‐regulatory hormone hepcidin. To study the largely unknown regulation of iron metabolism in the context of hepatic disease, we used two established models of chronic liver injury, ie repeated carbon tetrachloride (CCl4) or thioacetamide (TAA) injections. To determine the impact of CCAAT/enhancer‐binding protein (C/EBP)‐homologous protein (CHOP) on hepcidin production, the effect of a single TAA injection was determined in wild‐type and CHOP knockout mice. Furthermore, CHOP and hepcidin expression was assessed in control subjects and patients with alcoholic liver disease. Both chronic injury models developed a distinct iron overload in macrophages. TAA‐, but not CCl4‐ injected mice displayed additional iron accumulation in hepatocytes, resulting in a significant hepatic and systemic iron overload which was due to suppressed hepcidin levels. C/EBPα signalling, a known hepcidin inducer, was markedly inhibited in TAA mice, due to lower C/EBPα levels and overexpression of CHOP, a C/EBPα inhibitor. A single TAA injection resulted in a long‐lasting (> 6 days) suppression of hepcidin levels and CHOP knockouts (compared to wild‐types) displayed significantly attenuated hepcidin down‐regulation in response to acute TAA administration. CHOP mRNA levels increased 5‐fold in alcoholic liver disease patients versus controls (p < 0.005) and negatively correlated with hepcidin expression. Our results establish CHOP as an important regulator of hepatic hepcidin expression in chronic liver disease. The differences in iron metabolism between the two widely used fibrosis models likely reflect the differential regulation of hepcidin expression in human liver disease. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
10.